Swiss Re AG Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

Shareholders might have noticed that Swiss Re AG (VTX:SREN) filed its third-quarter result this time last week. The early response was not positive, with shares down 7.4% to CHF140 in the past week. It looks like a credible result overall - although revenues of US$11b were in line with what the analysts predicted, Swiss Re surprised by delivering a statutory profit of US$4.60 per share, a notable 13% above expectations. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, the consensus forecast from Swiss Re's twelve analysts is for revenues of US$44.5b in 2026. This reflects a reasonable 2.6% improvement in revenue compared to the last 12 months. Statutory per-share earnings are expected to be US$16.37, roughly flat on the last 12 months. In the lead-up to this report, the analysts had been modelling revenues of US$44.5b and earnings per share (EPS) of US$16.57 in 2026. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

Check out our latest analysis for Swiss Re

The analysts reconfirmed their price target of CHF144, showing that the business is executing well and in line with expectations. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. Currently, the most bullish analyst values Swiss Re at CHF171 per share, while the most bearish prices it at CHF125. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

Of course, another way to look at these forecasts is to place them into context against the industry itself. For example, we noticed that Swiss Re's rate of growth is expected to accelerate meaningfully, with revenues forecast to exhibit 2.0% growth to the end of 2026 on an annualised basis. That is well above its historical decline of 0.7% a year over the past five years. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 1.8% annually. So while Swiss Re's revenues are expected to improve, it seems that it is expected to grow at about the same rate as the overall industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target held steady at CHF144, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Swiss Re going out to 2027, and you can see them free on our platform here.

You should always think about risks though. Case in point, we've spotted 2 warning signs for Swiss Re you should be aware of, and 1 of them can't be ignored.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.